GT
BEAM icon

Glenmede Trust’s Beam Therapeutics BEAM Stock Holding History

Glenmede Trust’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-4,552
Closed -$216K – 1287
2022
Q3 		$216K Buy
+4,552
New +$260K ﹤0.01% 1065
2022
Q2 		– Sell
-7,437
Closed -$425K – 1296
2022
Q1 		$425K Buy
7,437
+50
+0.7% +$3.28K ﹤0.01% 944
2021
Q4 		$588K Buy
7,387
+100
+1% +$8.56K ﹤0.01% 879
2021
Q3 		$633K Sell
7,287
-56
-0.8% -$5.63K ﹤0.01% 831
2021
Q2 		$945K Buy
7,343
+2,903
+65% +$231K ﹤0.01% 717
2021
Q1 		$355K Buy
4,440
+1,440
+48% +$137K ﹤0.01% 936
2020
Q4 		$244K Hold
3,000
– – ﹤0.01% 1010
2020
Q3 		$73K Buy
+3,000
New +$74.4K ﹤0.01% 1251

Other funds holding BEAM

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return